These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3416271)

  • 1. Immunosuppressive substance in the sera of head and neck cancer patients.
    Yamanaka N; Harabuchi Y; Himi T; Kataura A
    Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of immunosuppressive factors (IAP-immunosuppressive acidic protein, IS-immunosuppressive substance) in head and neck cancer].
    Saito T; Dake Y; Kakiuti H; Kato Y; Kuki K; Hayashi Y; Yokota M; Kinoshita K; Kuki S; Kimura T
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Apr; 92(4):588-96. PubMed ID: 2769476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
    Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
    Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the serum level of immunosuppressive substance in oral cancer patients.
    Kubota E; Kurokawa H; Katsuki T
    J Oral Maxillofac Surg; 1991 Feb; 49(2):121-6. PubMed ID: 1990088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
    Ueda T; Yasumasu T; Uozumi J; Naito S
    Br J Urol; 1993 Oct; 72(4):409-12. PubMed ID: 8261296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive acidic protein in patients with gynecologic cancer].
    Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients.
    Nakashima T; Tanaka M; Okamura S
    J Laryngol Otol; 1991 Nov; 105(11):939-45. PubMed ID: 1761949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
    Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
    Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunosuppressive acidic protein in human ovarian cancer.
    Lin YH; Chow SN; Chen CK; Chen RJ; Huang SC; Huang GT
    J Formos Med Assoc; 1994 Sep; 93(9):776-80. PubMed ID: 7735007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
    Kikuchi S
    Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK.
    Sakamoto J; Koike A; Saji S; Teramukai S; Ohashi Y; Nakazato H
    Surg Today; 1992; 22(6):530-6. PubMed ID: 1472793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive acidic protein in patients with ovarian cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1983 Dec; 52(11):2081-5. PubMed ID: 6627216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
    Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
    Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
    Sato T; Sakata Y; Tamura K
    Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunosuppressive acidic protein levels in blackfoot disease patients and cancer patients.
    Lu FJ; Chang KJ; Chen BH; Liaw FR; Liau SR; Chen HY
    J Formos Med Assoc; 1990 Apr; 89(4):255-8. PubMed ID: 1976740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.